Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

CTB-Insulin oral vaccine produced in silkworm larvae protects NOD mice from autoimmune diabetes

Oct. 5, 2005

EGF/gastrin combination, E1-INT, reverses hyperglycemia and increases beta-cell mass

Oct. 5, 2005

AVR-118 begins phase I study in type 2 diabetes patients

Oct. 5, 2005

Phase II program cleared for cholesterol-lowering drug FM-VP4

Oct. 5, 2005

Hypoglycemic effects of FR-225654 in preclinical models of diabetes

Oct. 5, 2005

Clinical hold maintained on erectile dysfunction study of alagebrium

Oct. 4, 2005

ConjuChem updates DAC:GLP-1 and PC-DAC:Exendin-4 programs

Oct. 4, 2005

Pharming to study rhC1INH for new indications

Oct. 4, 2005

Promising results reported for Nastech's intranasal PTH (1-34) formulation

Oct. 4, 2005

Preclinical data on Ostabolin-C

Oct. 4, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Regeneron’s fianlimab lags in melanoma, does $2.3B deal with Parabilis
BioWorld
Regeneron Pharmaceuticals Inc. stuck with the tradition of releasing bad news on Friday afternoon and good news on Monday morning with a pair of announcements...